Literature DB >> 1494356

Antagonisms of potential concern in the clinical use of antifungal imidazoles and related azole-type drugs.

W H Beggs.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1494356     DOI: 10.1007/bf00436388

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


× No keyword cloud information.
  7 in total

1.  Resistance of Candida albicans to direct lethal miconazole action induced by low-level miconazole.

Authors:  W H Beggs
Journal:  Mycoses       Date:  1991 May-Jun       Impact factor: 4.377

2.  Regulation of the direct fungicidal action of miconazole against Candida albicans ATCC 26790.

Authors:  W H Beggs
Journal:  Mycoses       Date:  1988-04       Impact factor: 4.377

3.  Exploitation of the direct cell damaging action of antifungal azoles.

Authors:  W H Beggs; C E Hughes
Journal:  Diagn Microbiol Infect Dis       Date:  1987-01       Impact factor: 2.803

4.  Antagonism of the direct fungicidal action of miconazole by miconazole fungistasis.

Authors:  W H Beggs; I R LaSota; C E Hughes
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-06       Impact factor: 3.267

Review 5.  Overview of medically important antifungal azole derivatives.

Authors:  R A Fromtling
Journal:  Clin Microbiol Rev       Date:  1988-04       Impact factor: 26.132

Review 6.  Clinical pharmacokinetics of systemic antifungal drugs.

Authors:  T K Daneshmend; D W Warnock
Journal:  Clin Pharmacokinet       Date:  1983 Jan-Feb       Impact factor: 6.447

Review 7.  New antifungal agents for the systemic mycoses.

Authors:  S M Ringel
Journal:  Mycopathologia       Date:  1990-02       Impact factor: 2.574

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.